Fangcen Liu

732 total citations
18 papers, 518 citations indexed

About

Fangcen Liu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fangcen Liu has authored 18 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Fangcen Liu's work include Cancer Immunotherapy and Biomarkers (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Immunotherapy and Immune Responses (4 papers). Fangcen Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Immunotherapy and Immune Responses (4 papers). Fangcen Liu collaborates with scholars based in China and United States. Fangcen Liu's co-authors include Jia Wei, Tao Shi, Xueru Song, Yue Wang, Baorui Liu, Xingwen Wang, Xiaogang Li, Yue Wang, Mimi Wan and Huan Chen and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Fangcen Liu

17 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangcen Liu China 9 191 182 155 118 90 18 518
Taronish D. Dubash United States 12 54 0.3× 287 1.6× 360 2.3× 182 1.5× 46 0.5× 15 685
Elise Lavergne France 14 263 1.4× 262 1.4× 248 1.6× 71 0.6× 47 0.5× 16 665
Reeti Behera United States 7 61 0.3× 175 1.0× 227 1.5× 87 0.7× 52 0.6× 10 571
Changlin Yang United States 13 295 1.5× 263 1.4× 229 1.5× 95 0.8× 33 0.4× 46 660
Kyle R. Cron United States 4 584 3.1× 299 1.6× 219 1.4× 85 0.7× 20 0.2× 10 794
Daniel Wilkinson United States 13 377 2.0× 290 1.6× 168 1.1× 88 0.7× 35 0.4× 21 699
Jeff Wyckoff United States 5 117 0.6× 227 1.2× 228 1.5× 82 0.7× 35 0.4× 6 507
Michael J. Hollander United States 7 122 0.6× 148 0.8× 247 1.6× 69 0.6× 32 0.4× 9 467
Zofia Pilch Poland 10 182 1.0× 177 1.0× 110 0.7× 63 0.5× 16 0.2× 21 367
Joost A.P. Rens Netherlands 12 94 0.5× 148 0.8× 266 1.7× 197 1.7× 24 0.3× 15 596

Countries citing papers authored by Fangcen Liu

Since Specialization
Citations

This map shows the geographic impact of Fangcen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangcen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangcen Liu more than expected).

Fields of papers citing papers by Fangcen Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangcen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangcen Liu. The network helps show where Fangcen Liu may publish in the future.

Co-authorship network of co-authors of Fangcen Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangcen Liu. A scholar is included among the top collaborators of Fangcen Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangcen Liu. Fangcen Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Peng, Rui, Shiyao Du, Lixia Yu, et al.. (2024). Liposome‐based in situ antigen‐modification strategy for “universal” T‐cell‐receptor engineered T cell in cancer immunotherapy. SHILAP Revista de lepidopterología. 5(7). e618–e618. 3 indexed citations
3.
4.
Liu, Fangcen, et al.. (2023). Necroptosis Related Genes Predict Prognosis and Therapeutic Potential in Gastric Cancer. Biomolecules. 13(1). 101–101. 8 indexed citations
5.
Chu, Yanhong, Yaohua Ke, Xiaoyu Feng, et al.. (2022). Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma. Journal of Nanobiotechnology. 20(1). 190–190. 40 indexed citations
6.
Shi, Tao, Xueru Song, Yuting Luo, et al.. (2022). DKK1 Promotes Tumor Immune Evasion and Impedes Anti–PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer. Cancer Immunology Research. 10(12). 1506–1524. 65 indexed citations
7.
8.
Sha, Huizi, Qin Liu, Li Xie, et al.. (2022). Case Report: Pathological Complete Response in a Lung Metastasis of Phyllodes Tumor Patient Following Treatment Containing Peptide Neoantigen Nano-Vaccine. Frontiers in Oncology. 12. 800484–800484. 9 indexed citations
9.
Yuan, Shaohua, Rutian Li, Kai Wang, et al.. (2022). Systematic analysis of actionable gene fusions by NGS-based in pancancer for precision oncology in China.. Journal of Clinical Oncology. 40(16_suppl). e15072–e15072. 1 indexed citations
10.
Lu, Xiaofeng, Qin Liu, Song Liu, et al.. (2021). Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients. Frontiers in Oncology. 10. 554040–554040. 6 indexed citations
11.
Zhang, Wei, Hongdong Wang, Fangcen Liu, et al.. (2021). Effects of Early Intensive Insulin Therapy on Endothelial Progenitor Cells in Patients with Newly Diagnosed Type 2 Diabetes. Diabetes Therapy. 13(4). 679–690. 6 indexed citations
12.
Huang, Ying, et al.. (2021). KRAS gene status in gastric signet-ring cell carcinoma patients and acts as biomarker of MEK inhibitor. Journal of Gastrointestinal Oncology. 12(3). 1020–1030. 2 indexed citations
13.
Chen, Huan, Tao Shi, Yue Wang, et al.. (2021). Deep Penetration of Nanolevel Drugs and Micrometer-Level T Cells Promoted by Nanomotors for Cancer Immunochemotherapy. Journal of the American Chemical Society. 143(31). 12025–12037. 109 indexed citations
14.
Liu, Fangcen, Yanhong Chu, Qingqing Zhai, et al.. (2020). <p>MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT</p>. Cancer Management and Research. Volume 12. 12215–12223. 19 indexed citations
15.
Xu, Bo, Fangcen Liu, Qin Liu, et al.. (2020). Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC). Journal of Gastrointestinal Oncology. 11(6). 1431–1439. 33 indexed citations
16.
Shi, Tao, Xueru Song, Yue Wang, Fangcen Liu, & Jia Wei. (2020). Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment. Frontiers in Immunology. 11. 683–683. 128 indexed citations
17.
Liu, Fangcen, et al.. (2020). Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer. Cancer Medicine. 9(19). 7137–7150. 2 indexed citations
18.
Wang, Hongdong, Lei Shen, Xitai Sun, et al.. (2019). Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity. Nature Communications. 10(1). 3254–3254. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taronish D. Dubash Breakdown of academic impact, for papers by Elise Lavergne Breakdown of academic impact, for papers by Reeti Behera Breakdown of academic impact, for papers by Changlin Yang Breakdown of academic impact, for papers by Kyle R. Cron Breakdown of academic impact, for papers by Daniel Wilkinson Breakdown of academic impact, for papers by Jeff Wyckoff Breakdown of academic impact, for papers by Michael J. Hollander Breakdown of academic impact, for papers by Zofia Pilch Breakdown of academic impact, for papers by Joost A.P. Rens
Rankless by CCL
2026